Cargando…
Cardiac dysfunction in Multisystem Inflammatory Syndrome in Children: An Italian single-center study
BACKGROUND: Multisystem inflammatory syndrome in children (MIS-C) is a novel condition temporally associated with SARS-CoV2 infection. Cardiovascular involvement is mainly evident as acute myocardial dysfunction in MIS-C. The aim of this study was to describe the cardiac dysfunction in patients with...
Autores principales: | , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8822778/ https://www.ncbi.nlm.nih.gov/pubmed/35135600 http://dx.doi.org/10.1186/s13052-021-01189-z |
_version_ | 1784646670022082560 |
---|---|
author | Mannarino, Savina Raso, Irene Garbin, Massimo Ghidoni, Elena Corti, Carla Goletto, Sara Nespoli, Luisa Santacesaria, Sara Zoia, Elena Camporesi, Anna Izzo, Francesca Dilillo, Dario Fiori, Laura D’Auria, Enza Silvestri, Annalisa De Dolci, Alberto Calcaterra, Valeria Zuccotti, Gianvincenzo |
author_facet | Mannarino, Savina Raso, Irene Garbin, Massimo Ghidoni, Elena Corti, Carla Goletto, Sara Nespoli, Luisa Santacesaria, Sara Zoia, Elena Camporesi, Anna Izzo, Francesca Dilillo, Dario Fiori, Laura D’Auria, Enza Silvestri, Annalisa De Dolci, Alberto Calcaterra, Valeria Zuccotti, Gianvincenzo |
author_sort | Mannarino, Savina |
collection | PubMed |
description | BACKGROUND: Multisystem inflammatory syndrome in children (MIS-C) is a novel condition temporally associated with SARS-CoV2 infection. Cardiovascular involvement is mainly evident as acute myocardial dysfunction in MIS-C. The aim of this study was to describe the cardiac dysfunction in patients with MIS-C, defining the role of severity in the clinical presentations and outcomes in a single cohort of pediatric patients. METHODS: A single-center retrospective study on patients diagnosed with MIS-C, according to the Center for Disease Control and Prevention (CDC) definition, and referred to Vittore Buzzi Children’s Hospital in Milan from November 2020 to February 2021. Patients were managed according to a local approved protocol. According to the admission cardiac left ventricular ejection fraction (LVEF), the patients were divided into group A (LVEF < 45%) and group B (LVEF ≥45%). Pre-existing, clinical, and laboratory factors were assessed for evaluating outcomes at discharge. RESULTS: Thirty-two patients were considered. Cardiac manifestations of MIS-C were reported in 26 patients (81%). Group A included 10 patients (9 M/1F, aged 13 years [IQR 5–15]), and group B included 22 patients (15 M/7 M, aged 9 years [IQR 7–13]). Significant differences were noted among clinical presentations (shock, diarrhea, intensive care unit admission), laboratory markers (leucocytes, neutrophils, and protein C-reactive), and cardiac markers (troponin T and N-terminal pro B-type Natriuretic Peptide) between the groups, with higher compromission in Group A. We found electrocardiogram anomalies in 14 patients (44%) and rhythm alterations in 3 patients (9%), without differences between groups. Mitral regurgitation and coronary involvement were more prevalent in group A. Total length of hospital stay and cardiac recovery time were not statistically different between groups. A recovery of cardiac functioning was reached in all patients. CONCLUSION: Despite significant differences in clinical presentations and need for intensive care, all of the MIS-C patients with significant cardiac involvement in this study completely recovered. This suggests that the heart is an involved organ and did not influence prognosis if properly treated and supported in the acute phase. |
format | Online Article Text |
id | pubmed-8822778 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-88227782022-02-08 Cardiac dysfunction in Multisystem Inflammatory Syndrome in Children: An Italian single-center study Mannarino, Savina Raso, Irene Garbin, Massimo Ghidoni, Elena Corti, Carla Goletto, Sara Nespoli, Luisa Santacesaria, Sara Zoia, Elena Camporesi, Anna Izzo, Francesca Dilillo, Dario Fiori, Laura D’Auria, Enza Silvestri, Annalisa De Dolci, Alberto Calcaterra, Valeria Zuccotti, Gianvincenzo Ital J Pediatr Research BACKGROUND: Multisystem inflammatory syndrome in children (MIS-C) is a novel condition temporally associated with SARS-CoV2 infection. Cardiovascular involvement is mainly evident as acute myocardial dysfunction in MIS-C. The aim of this study was to describe the cardiac dysfunction in patients with MIS-C, defining the role of severity in the clinical presentations and outcomes in a single cohort of pediatric patients. METHODS: A single-center retrospective study on patients diagnosed with MIS-C, according to the Center for Disease Control and Prevention (CDC) definition, and referred to Vittore Buzzi Children’s Hospital in Milan from November 2020 to February 2021. Patients were managed according to a local approved protocol. According to the admission cardiac left ventricular ejection fraction (LVEF), the patients were divided into group A (LVEF < 45%) and group B (LVEF ≥45%). Pre-existing, clinical, and laboratory factors were assessed for evaluating outcomes at discharge. RESULTS: Thirty-two patients were considered. Cardiac manifestations of MIS-C were reported in 26 patients (81%). Group A included 10 patients (9 M/1F, aged 13 years [IQR 5–15]), and group B included 22 patients (15 M/7 M, aged 9 years [IQR 7–13]). Significant differences were noted among clinical presentations (shock, diarrhea, intensive care unit admission), laboratory markers (leucocytes, neutrophils, and protein C-reactive), and cardiac markers (troponin T and N-terminal pro B-type Natriuretic Peptide) between the groups, with higher compromission in Group A. We found electrocardiogram anomalies in 14 patients (44%) and rhythm alterations in 3 patients (9%), without differences between groups. Mitral regurgitation and coronary involvement were more prevalent in group A. Total length of hospital stay and cardiac recovery time were not statistically different between groups. A recovery of cardiac functioning was reached in all patients. CONCLUSION: Despite significant differences in clinical presentations and need for intensive care, all of the MIS-C patients with significant cardiac involvement in this study completely recovered. This suggests that the heart is an involved organ and did not influence prognosis if properly treated and supported in the acute phase. BioMed Central 2022-02-08 /pmc/articles/PMC8822778/ /pubmed/35135600 http://dx.doi.org/10.1186/s13052-021-01189-z Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Mannarino, Savina Raso, Irene Garbin, Massimo Ghidoni, Elena Corti, Carla Goletto, Sara Nespoli, Luisa Santacesaria, Sara Zoia, Elena Camporesi, Anna Izzo, Francesca Dilillo, Dario Fiori, Laura D’Auria, Enza Silvestri, Annalisa De Dolci, Alberto Calcaterra, Valeria Zuccotti, Gianvincenzo Cardiac dysfunction in Multisystem Inflammatory Syndrome in Children: An Italian single-center study |
title | Cardiac dysfunction in Multisystem Inflammatory Syndrome in Children: An Italian single-center study |
title_full | Cardiac dysfunction in Multisystem Inflammatory Syndrome in Children: An Italian single-center study |
title_fullStr | Cardiac dysfunction in Multisystem Inflammatory Syndrome in Children: An Italian single-center study |
title_full_unstemmed | Cardiac dysfunction in Multisystem Inflammatory Syndrome in Children: An Italian single-center study |
title_short | Cardiac dysfunction in Multisystem Inflammatory Syndrome in Children: An Italian single-center study |
title_sort | cardiac dysfunction in multisystem inflammatory syndrome in children: an italian single-center study |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8822778/ https://www.ncbi.nlm.nih.gov/pubmed/35135600 http://dx.doi.org/10.1186/s13052-021-01189-z |
work_keys_str_mv | AT mannarinosavina cardiacdysfunctioninmultisysteminflammatorysyndromeinchildrenanitaliansinglecenterstudy AT rasoirene cardiacdysfunctioninmultisysteminflammatorysyndromeinchildrenanitaliansinglecenterstudy AT garbinmassimo cardiacdysfunctioninmultisysteminflammatorysyndromeinchildrenanitaliansinglecenterstudy AT ghidonielena cardiacdysfunctioninmultisysteminflammatorysyndromeinchildrenanitaliansinglecenterstudy AT corticarla cardiacdysfunctioninmultisysteminflammatorysyndromeinchildrenanitaliansinglecenterstudy AT golettosara cardiacdysfunctioninmultisysteminflammatorysyndromeinchildrenanitaliansinglecenterstudy AT nespoliluisa cardiacdysfunctioninmultisysteminflammatorysyndromeinchildrenanitaliansinglecenterstudy AT santacesariasara cardiacdysfunctioninmultisysteminflammatorysyndromeinchildrenanitaliansinglecenterstudy AT zoiaelena cardiacdysfunctioninmultisysteminflammatorysyndromeinchildrenanitaliansinglecenterstudy AT camporesianna cardiacdysfunctioninmultisysteminflammatorysyndromeinchildrenanitaliansinglecenterstudy AT izzofrancesca cardiacdysfunctioninmultisysteminflammatorysyndromeinchildrenanitaliansinglecenterstudy AT dilillodario cardiacdysfunctioninmultisysteminflammatorysyndromeinchildrenanitaliansinglecenterstudy AT fiorilaura cardiacdysfunctioninmultisysteminflammatorysyndromeinchildrenanitaliansinglecenterstudy AT dauriaenza cardiacdysfunctioninmultisysteminflammatorysyndromeinchildrenanitaliansinglecenterstudy AT silvestriannalisade cardiacdysfunctioninmultisysteminflammatorysyndromeinchildrenanitaliansinglecenterstudy AT dolcialberto cardiacdysfunctioninmultisysteminflammatorysyndromeinchildrenanitaliansinglecenterstudy AT calcaterravaleria cardiacdysfunctioninmultisysteminflammatorysyndromeinchildrenanitaliansinglecenterstudy AT zuccottigianvincenzo cardiacdysfunctioninmultisysteminflammatorysyndromeinchildrenanitaliansinglecenterstudy |